Logo

American Heart Association

  21
  0


Final ID: MP478

Self-reported History of Heart Attack among Patients with Type 1 versus Type 2 Myocardial Infarction

Abstract Body (Do not enter title and authors here): Background:
The term “heart attack” is synonymous with myocardial infarction (MI). Epidemiologic studies that track MI incidence often rely on patient self-reported history of heart attack. We sought to compare patient self-reported history of heart attack shortly after a diagnosis of type 1 MI (T1MI) and type 2 MI (T2MI).
Methods:
In this single-center prospective cohort study, 150 consecutively eligible patients meeting strict Universal Definition of MI criteria for T1MI (n=75) and T2MI (n=75) were enrolled. Participants completed baseline (during their index MI hospitalization) and 1-month (4-6 weeks post-discharge) FRAIL scale questionnaires, including the question: “Did your doctor ever tell you that you have had a heart attack?” Multivariable logistic regression analysis evaluated the association between patient characteristics (age, sex, prior MI before the index MI, and presenting MI subtype) and self-reported history of heart attack.
Results:
149 baseline questionnaires and 92 1-month questionnaires were available at the time of this analysis, in which 108 participants (72%) self-reported a diagnosis of heart attack at either baseline or 1 month. Among all participants (n=149), individuals who were White (79.6% vs 61.0%, p=0.006) and who had a prior MI before their index MI (24.1% vs 7.3%, p=0.04) more commonly self-reported a heart attack. Patients with T2MI less commonly reported having had a heart attack shortly after their MI as compared to T1MI (54.7% vs 90.5%, p<0.001). Among individuals with T2MI (n=75), individuals with a prior MI before their index MI (31.7% vs 8.8%, p=0.03), higher peak high-sensitivity troponin concentrations (363 ng/L [IQR, 132, 673] vs 139 ng/L [73, 363], p=0.02), and those who underwent invasive coronary angiography (63.4% vs 29.4%, p=0.007) more often self-reported a heart attack. After adjusting for age, gender, race, and prior MI, T2MI patients were significantly less likely to report a history of heart attack than T1MI patients (odds ratio: 0.13 [95% CI, 0.04, 0.32]).
Conclusion:
Individuals who experienced a T2MI were almost 8 times less likely to report having had a heart attack shortly after their MI event as compared to those with T1MI. These results suggest that epidemiology studies that rely on self-reported history of heart attack may not accurately capture all MI subtypes. Further research is needed to better understand how clinicians communicate a diagnosis of T2MI and patients’ understanding of the diagnosis.
  • Luterstein, Elaine  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Kitzman, Dalane  ( Wake Forest University School of Medicine , Winston-Salem , North Carolina , United States )
  • Spertus, John  ( University of Missouri-Kansas City’s Healthcare Institute for Innovations in Quality and Saint Luke's Mid America Heart Institute , Kansas City , Missouri , United States )
  • Huffman, Jeff  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Natarajan, Pradeep  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Januzzi, James  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Mccarthy, Cian  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Tong, Nhi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Murphy, Sean  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Raghavan, Avanthi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Paquette, Charlotte  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Lin, Claire  ( Harvard Medical School , Boston , Massachusetts , United States )
  • Liu, Yuxi  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Wasfy, Jason  ( Massachusetts General Brigham , Boston , Massachusetts , United States )
  • Doros, Gheorghe  ( Boston University School of Public Health , Boston , Massachusetts , United States )
  • Author Disclosures:
    Elaine Luterstein: DO NOT have relevant financial relationships | Dalane Kitzman: No Answer | John Spertus: DO have relevant financial relationships ; Consultant:BioHaven, Janssen, Bristol Meyers Squibb, Terumo, Cytokinetics, BridgeBio, VentricHealth, and Imbria:Active (exists now) ; Executive Role:Blue Cross Blue Shield of Kansas City:Active (exists now) ; Royalties/Patent Beneficiary:SAQ, KCCQ, PAQ:Active (exists now) | Jeff Huffman: No Answer | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Amgen, Genentech / Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Vertex Pharmaceuticals (spousal employment):Active (exists now) ; Ownership Interest:Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli, TenSixteen Bio:Active (exists now) ; Consultant:Allelica, CRISPR Therapeutics, Genentech/Roche, HeartFlow, Magnet Biomedicine:Past (completed) ; Consultant:AstraZeneca, Blackstone Life Sciences, Bristol Myers Squibb, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, GV, Merck, Novartis, Novo Nordisk, TenSixteen Bio, Tourmaline Bio:Active (exists now) ; Researcher:Allelica, Novartis:Past (completed) | James Januzzi: DO have relevant financial relationships ; Individual Stocks/Stock Options:Imbria:Active (exists now) ; Researcher:Celecor:Active (exists now) ; Consultant:Roche:Active (exists now) ; Consultant:Jana Care:Active (exists now) ; Consultant:Beckman:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:BMS:Active (exists now) ; Researcher:AstraZeneca:Active (exists now) ; Researcher:Applied Therapeutics:Active (exists now) ; Researcher:Abbott:Active (exists now) ; Individual Stocks/Stock Options:Prevencio:Active (exists now) ; Individual Stocks/Stock Options:Fibrosys:Active (exists now) ; Individual Stocks/Stock Options:Jana Care:Active (exists now) | Cian McCarthy: DO have relevant financial relationships ; Consultant:HeartFlow:Active (exists now) ; Consultant:NewAmsterdam Pharma:Active (exists now) ; Consultant:Abbott Laboratories:Past (completed) ; Consultant:Roche Diagnostics:Active (exists now) | Nhi Tong: No Answer | Sean Murphy: DO NOT have relevant financial relationships | Avanthi Raghavan: DO NOT have relevant financial relationships | Charlotte Paquette: DO NOT have relevant financial relationships | Claire Lin: No Answer | Yuxi Liu: DO NOT have relevant financial relationships | Jason Wasfy: DO NOT have relevant financial relationships | Gheorghe Doros: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cracking the Code of Coronary Care: Timing, Trials, and Turning Points in Acute MI Management

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Changes in decisional conflict among adults with atrial fibrillation viewing a rhythm management decision aid: Results from a single-arm feasibility trial

Reading Turchioe Meghan, Shamnath Afra, Zhao Yihong, Volodarskiy Alexander, Slotwiner David, Biviano Angelo

A Novel ECG Time-Frequency Eyeball Method for Robust Detection of Myocardial Infarction from Single-Channel ECG: A Preclinical Study

Alavi Rashid, Li Jiajun, Dai Wangde, Matthews Ray, Pahlevan Niema, Kloner Robert, Gharib Morteza

More abstracts from these authors:
Risk Scores and Hypertension Management

Mccarthy Cian

Temporal Trends and Predictors of Cardiac Biomarker Testing in the Emergency Department, 2014-2021

Watson Nathan, Wasfy Jason, Baugh Christopher, Januzzi James, Secemsky Eric, Mccarthy Cian

You have to be authorized to contact abstract author. Please, Login
Not Available